(Q71477704)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

Serum concentrations of basic fibroblast growth factor in collagen diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

T Kadono

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

K Kikuchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

M Kubo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

M Fujimoto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

K Tamaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

language of work or name

English

0 references

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

18 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

3 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

392-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells

18 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Observations in the potential role of transforming growth factor-beta in cutaneous fibrosis. Systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Plasma TGF beta in systemic sclerosis: a cross-sectional study.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Immunoassay of platelet-derived growth factor in the plasma of patients with scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Differential modulation of bFGF receptors by TGF-beta in adult skin, scleroderma skin, and newborn foreskin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Antinuclear antibodies in the relatives of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Improved enzyme immunoassay for human basic fibroblast growth factor using a new enhanced chemiluminescence system.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Elevated plasma endothelin levels in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

Interleukin-1, Interleukin-2, Interleukin-4, Interleukin-6, Tumor Necrosis Factor α, and Interferon-γ Levels in Sera from Patients With Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990603-9

7 January 2021

10.1016/S0190-9622(96)90603-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8784275%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference